Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥675.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥239.1bn2023-10-01 → 2023-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥641.5bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥224.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥39.0bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥34.2bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥142.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥49.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥33.0bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥34.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥139.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥50.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥235.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥108.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥235.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥108.4bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥1.47Tat 2023-12-31Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.39Tat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥718.2bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥867.5bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥749.9bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥605.6bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥749.9bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥604.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥348.6bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥211.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥12.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥54.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥391.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥37.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥240.8bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥112.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥191.592023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.842023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥191.152023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.812023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥85.042022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.62022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio51.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥29.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31¥83.6bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-12-31¥971m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥16.2bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥68.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥15.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥110.7bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-12-31−¥917m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥48.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥157.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 747
ItemContextValueUnit
Capital surplus IFRSCurrentQuarterInstant91405000000JPY
Treasury shares IFRSPrior1YearInstant-28086000000JPY
Treasury shares IFRSCurrentQuarterInstant-168482000000JPY
Other components of equity IFRSPrior1YearInstant77280000000JPY
Other components of equity IFRSCurrentQuarterInstant116317000000JPY
Other components of capital related to the disposal group held for sale equity IFRSPrior1YearInstant3034000000JPY
Other components of capital related to the disposal group held for sale equity IFRSCurrentQuarterInstant-JPY
Retained earnings IFRSPrior1YearInstant371064000000JPY
Retained earnings IFRSCurrentQuarterInstant585999000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant640085000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant749882000000JPY
Non controlling interests IFRSPrior1YearInstant1149000000JPY
Non controlling interests IFRSCurrentQuarterInstant-JPY
Equity IFRSPrior1YearInstant641234000000JPY
Equity IFRSCurrentQuarterInstant749882000000JPY
Liabilities and equity IFRSPrior1YearInstant1508701000000JPY
Liabilities and equity IFRSCurrentQuarterInstant1468078000000JPY
Net sales IFRSPrior1YTDDuration641545000000JPY
Net sales IFRSCurrentYTDDuration675714000000JPY
Cost of sales IFRSPrior1YTDDuration207821000000JPY
Cost of sales IFRSCurrentYTDDuration224281000000JPY
Gross profit IFRSPrior1YTDDuration433724000000JPY
Gross profit IFRSCurrentYTDDuration451433000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration306085000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration340907000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration490000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-354000000JPY
Other income IFRSPrior1YTDDuration21911000000JPY
Other income IFRSCurrentYTDDuration3334000000JPY
Other expenses IFRSPrior1YTDDuration7468000000JPY
Other expenses IFRSCurrentYTDDuration74471000000JPY
Operating profit loss IFRSPrior1YTDDuration142572000000JPY
Operating profit loss IFRSCurrentYTDDuration39035000000JPY
Finance income IFRSPrior1YTDDuration2983000000JPY
Finance income IFRSCurrentYTDDuration1876000000JPY
Finance costs IFRSPrior1YTDDuration6185000000JPY
Finance costs IFRSCurrentYTDDuration7893000000JPY
Profit loss before tax IFRSPrior1YTDDuration139370000000JPY
Profit loss before tax IFRSCurrentYTDDuration33018000000JPY
Income tax expense IFRSPrior1YTDDuration33751000000JPY
Income tax expense IFRSCurrentYTDDuration25529000000JPY
Profit loss from continuing operations IFRSPrior1YTDDuration105619000000JPY
Profit loss from continuing operations IFRSCurrentYTDDuration7489000000JPY
Profit loss from discontinued operations IFRSPrior1YTDDuration2750000000JPY
Profit loss from discontinued operations IFRSCurrentYTDDuration228086000000JPY
Profit loss IFRSPrior1YTDDuration108369000000JPY
Profit loss IFRSCurrentYTDDuration235575000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration108217000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration235212000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration152000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass